These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 39021173)

  • 1. Revolutionizing Antibacterial Strategies: Lipid Nanoparticles as Game-Changers in Combatting Multi-Drug-Resistant Infections.
    P RB; Prajapati BG; Rajeshkumar R; Balasubramaniam V; Ponnusankar S
    Curr Med Chem; 2024 Jul; ():. PubMed ID: 39021173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.
    Lee HR; You DG; Kim HK; Sohn JW; Kim MJ; Park JK; Lee GY; Yoo YD
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291307
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Li Z; Shi L; Wang B; Wei X; Zhang J; Guo T; Kong J; Wang M; Xu H
    Appl Environ Microbiol; 2021 Feb; 87(6):. PubMed ID: 33361364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Nanocarrier Systems in Drug Delivery for Overcoming Multi-Drug Resistance in Bacteria.
    Qumsani AT
    Pak J Biol Sci; 2023 Feb; 26(3):131-137. PubMed ID: 37480270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoding antimicrobial resistance: unraveling molecular mechanisms and targeted strategies.
    Singh G; Rana A; Smriti
    Arch Microbiol; 2024 May; 206(6):280. PubMed ID: 38805035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomaterials as Delivery Vehicles and Components of New Strategies to Combat Bacterial Infections: Advantages and Limitations.
    Naskar A; Kim KS
    Microorganisms; 2019 Sep; 7(9):. PubMed ID: 31527443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial genome engineering and synthetic biology: combating pathogens.
    Krishnamurthy M; Moore RT; Rajamani S; Panchal RG
    BMC Microbiol; 2016 Nov; 16(1):258. PubMed ID: 27814687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology as a Promising Approach to Combat Multidrug Resistant Bacteria: A Comprehensive Review and Future Perspectives.
    Hetta HF; Ramadan YN; Al-Harbi AI; A Ahmed E; Battah B; Abd Ellah NH; Zanetti S; Donadu MG
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymol-Decorated Gold Nanoparticles for Curing Clinical Infections Caused by Bacteria Resistant to Last-Resort Antibiotics.
    Huang Z; Zhang X; Yao Z; Han Y; Ye J; Zhang Y; Chen L; Shen M; Zhou T
    mSphere; 2023 Jun; 8(3):e0054922. PubMed ID: 37017551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
    Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
    Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of Action of Isopropoxy Benzene Guanidine against Multidrug-Resistant Pathogens.
    Li J; Zhang X; Han N; Wan P; Zhao F; Xu T; Peng X; Xiong W; Zeng Z
    Microbiol Spectr; 2023 Feb; 11(1):e0346922. PubMed ID: 36475769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dealing with MDR bacteria and biofilm in the post-antibiotic era: Application of antimicrobial peptides-based nano-formulation.
    Song X; Liu P; Liu X; Wang Y; Wei H; Zhang J; Yu L; Yan X; He Z
    Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112318. PubMed ID: 34474869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial Peptides against Bacterial Pathogens: Innovative Delivery Nanosystems for Pharmaceutical Applications.
    Imperlini E; Massaro F; Buonocore F
    Antibiotics (Basel); 2023 Jan; 12(1):. PubMed ID: 36671385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macromolecular agents with antimicrobial potentialities: A drive to combat antimicrobial resistance.
    Bilal M; Rasheed T; Iqbal HMN; Hu H; Wang W; Zhang X
    Int J Biol Macromol; 2017 Oct; 103():554-574. PubMed ID: 28528940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens.
    Chen C; Shi J; Wang D; Kong P; Wang Z; Liu Y
    Crit Rev Microbiol; 2024 May; 50(3):267-284. PubMed ID: 36890767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-peptide conjugates for bacterial detection and neutralization: Potential applications in diagnostics and therapy.
    Gonçalves S; Martins IC; Santos NC
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Nov; 14(6):e1819. PubMed ID: 36416027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Potential of Antibiotics and Nanomaterial Combinations as Therapeutic Strategies in the Management of Multidrug-Resistant Infections: A Review.
    Adeniji OO; Nontongana N; Okoh JC; Okoh AI
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.
    Litwin A; Fedorowicz O; Duszynska W
    Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977435
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of multi-drug resistant bacteria associated with foods and drinks in Nigeria (2015-2020): A systematic review.
    Mola I; Onibokun A; Oranusi S
    Ital J Food Saf; 2021 Nov; 10(4):9417. PubMed ID: 35018289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulling the Brakes on Fast and Furious Multiple Drug-Resistant (MDR) Bacteria.
    Khan AA; Manzoor KN; Sultan A; Saeed M; Rafique M; Noushad S; Talib A; Rentschler S; Deigner HP
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.